Key points are not available for this paper at this time.
Subcutaneous administration of rapid-acting insulin normalizes blood glucose levels without compromising the quality of PET-CT studies when (18)F-FDG is administered not earlier than 4 h later.
García et al. (Mon,) studied this question.